Karyopharm Therapeutics Inc. (KPTI)
NASDAQ·Healthcare·Biotechnology
$0.48
-1.47%
Mkt Cap $10.89M
Analyst Ratings
Buy
2
Hold
1
Sell
0
Price Target (16 analysts)
$13.20
Range $3.00 – $28.00
Implied Upside
+2650.0%
Consensus $13.20 vs current $0.48
NASDAQ·Healthcare·Biotechnology
$0.48
-1.47%
Mkt Cap $10.89M
Buy
2
Hold
1
Sell
0
Price Target (16 analysts)
$13.20
Range $3.00 – $28.00
+2650.0%
Consensus $13.20 vs current $0.48